FL (Follicular Lymphoma),Lymphoma Loncastuximab & Rituximab Combo: Effective in Rel/Ref FL May 08, 2024
FL (Follicular Lymphoma),Lymphoma MTV as a Prognostic Indicator in Advanced Follicular Lymphoma Feb 22, 2024
FL (Follicular Lymphoma),Lymphoma LMR Predicts PFS And Early Relapse In High Tumor Burden FL Oct 26, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma Epcoritamab + R-CHOP Found Effective & Safe in 1st-Line High-Risk DLBCL Oct 23, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma Epcoritamab With Rituximab + R2 Show Durable Responses In High-risk FL Patients Oct 17, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Subcutaneous Epcoritamab Is Well-Tolerated And Effective In Patients With R/R LBCL Oct 05, 2023
